Clinical Trials Browser

Phase NA × OTHER × SLC25A33 protein, human × Clear all

NCT06785077 2025-01-20

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

Phase NA Recruiting

Classical hematologyGynecologicOther hematologic neoplasm

Carcinoma, Ovarian Epithelial, Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute